Eurobio Scientific offers a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations of interest Paris, May 26, 2021 – 7:30 am Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in the field of specialty in vitro medical diagnostics, announces today the availability of its new proprietary EurobioPlex SARS-CoV-2 SNPs test (EBX-046), a real-time multiplex PCR test for the detection of the SARS-CoV-2 coronavirus and the simultaneous typing of its new mutations. EBX-046 is a diagnostics test developed and manufactured in France by Eurobio Scientific, allowing, simultaneously in a single well and in a single PCR reaction, the detection on 2 genes of the SARS-CoV-2 virus and the characterization of the three mutations currently in interest: L452R (Californian and Indian variants), E484K (South African and Brazilian variants) and E484Q (Indian variant). The N501Y mutation linked to the British var